Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox-Reference-Cited by-同舟云学术

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

Published:2004-03 Issue:6979 Volume:428 Page:182-185
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Earl Patricia L.,Americo Jeffrey L.,Wyatt Linda S.,Eller Leigh Anne,Whitbeck J. Charles,Cohen Gary H.,Eisenberg Roselyn J.,Hartmann Christopher J.,Jackson David L.,Kulesh David A.,Martinez Mark J.,Miller David M.,Mucker Eric M.,Shamblin Joshua D.,Zwiers Susan H.,Huggins John W.,Jahrling Peter B.,Moss Bernard

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature02331.pdf

Reference30 articles.

1. Fulginiti, V. A., Papier, A., Lane, J. M., Neff, J. M. & Henderson, D. A. Smallpox vaccination: a review, part II. Adverse events. Clin. Infect. Dis. 37, 251–271 (2003)

2. Mayr, A., Hochstein-Mintzel, V. & Stickl, H. Abstammung, eigenschaften und verwendung des attenuierten vaccinia-stammes MVA [Passage history, properties, and applicability of the attenuated vaccinia virus strain MVA]. Infection 3, 6–14 (1975)

3. Meyer, H., Sutter, G. & Mayr, A. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. J. Gen. Virol. 72, 1031–1038 (1991)

4. Antoine, G., Scheiflinger, F., Dorner, F. & Falkner, F. G. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244, 365–396 (1998)

5. Carroll, M. & Moss, B. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line. Virology 238, 198–211 (1997)

Cited by 398 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccines against mpox: MVA-BN and LC16m8;Expert Review of Vaccines;2024-09

2. Recent research advances in the development of Dabie Banda virus vaccines;PLOS Neglected Tropical Diseases;2024-08-29

3. Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assays;Proceedings of the National Academy of Sciences;2024-07-08

4. A Penta-Component Mpox mRNA Vaccine Induced Protective Immunity in Naive and Simian Immunodeficiency Virus Infected Nonhuman Primates;2024-05-30

5. Understanding the biology of monkeypox virus to prevent future outbreaks;Nature Microbiology;2024-05-09